期刊文献+

瓦里安呼吸门控实时位置管理系统对放射治疗计划剂量学的影响 被引量:1

Impact of the Varian real-time position management respiratory gating system on radiotherapy planning dosimetry
原文传递
导出
摘要 目的研究瓦里安呼吸门控实时位置管理(RPM)系统对放射治疗计划剂量学的影响。方法回顾性选取40例胸腹部肿瘤放疗计划,采用质量控制运动模体产生呼吸门控信号,选取呼气末30%~60%稳定时相作为呼吸门控窗,在Edge加速器RPM呼吸门控模式下对上述计划进行Portal Dosimetry(PD)系统剂量验证,采用不同的γ通过率标准进行剂量分析,并分析其γ值的分布特点,与非门控模式下验证结果进行对比。结果在RPM呼吸门控模式下,对于不同均整器模式下的调强放射治疗计划(IMRT)或容积调强放射治疗计划(VMAT),采用γ(3%,3 mm)或(3%,2 mm)标准,所有计划通过率均在95.5%以上,采用更严格的γ(2%,2 mm)标准,所有计划通过率均在90%以上,符合美国医学物理师学会(AAPM)推荐的临床治疗标准。非门控模式下剂量验证结果通过率略优于呼吸门控模式下验证结果,两种模式下差异具有统计学意义(3%/3 mm,Z=-1.45;3%/2 mm,Z=-2.86;2%/2 mm,Z=-3.70;1%/1 mm,Z=-4.52,P<0.05)。两种模式下计划验证结果γ值的最小值、最大值及γ>1.5的份额差异不明显,但非门控模式下γ的平均值及标准偏差总体更小。结论RPM呼吸门控技术引入带来的剂量影响在临床可接受范围内,该门控模式下计划执行是安全可靠的。 Objective To study the impact of the Varian real-time position management(RPM)respiratory gating system on radiotherapy planning dosimetry.Methods The radiotherapy plans of 40 cases with thoracic or abdominal tumors were retrospectively selected in this study.The motion phantom for quality control was adopted to generate respiratory gating signals,and the 30%-60%stable phase at the end of expiratory was selected as the respiratory gating window.The dose verification for the abovementioned radiotherapy plans was performed using the Portal Dosimetry(PD)system under RPM respiratory gating mode with the Edge accelerator.Afterwards,dose analysis was performed with differentγpassing rate criteria and the distribution characteristics ofγvalues were analyzed.Finally,the verification results between the non-gating mode and the gating mode were compared.Results Under the respiratory gating mode,the passing rates of all intensity-modulated radiation therapy/volumetric-modulated arc therapy(IMRT/VMAT)plans with or without flattening filters were over 95.5%byγcriteria of(3%,3 mm)or(3%,2 mm)and were over 90%by stricterγcriteria of(2%,2 mm).All plans met the clinical requirements recommended by the American Association of Physicists in Medicine(AAPM).The passing rates of dose verification under non-gating mode were slightly better than those under respiratory gating mode,and the differences between the two modes were statistically significant(3%/3 mm,Z=-1.45;3%/2 mm,Z=-2.86;2%/2 mm,Z=-3.70;1%/1 mm,Z=-4.52;P<0.05).There was no significant difference in the minimum and maximum values ofγand the share ofγ>1.5 of plan verification result under the two modes.However,the average value and standard deviation of theγwere generally smaller under the non-gating mode.Conclusions The impact of the introduction of RPM respiratory gating technology on dose is clinically acceptable,and the execution of these plans in this gating mode is safe and reliable.
作者 郑芳 钟鹤立 陈洪涛 李隆兴 张定 付鑫 史亚滨 李子煌 Zheng Fang;Zhong Heli;Chen Hongtao;Li Longxing;Zhang Ding;Fu Xin;Shi Yabin;Li Zihuang(Department of Radiation Oncology,Shenzhen People′s Hospital,The Second Clinical Medical College,Jinan University,The First Affiliated Hospital,Southern University of Science and Technology,Shenzhen 518020,China)
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2022年第9期685-690,共6页 Chinese Journal of Radiological Medicine and Protection
基金 深圳市科技研发资金(JCYJ20180305180540801)。
关键词 呼吸门控实时位置管理 Portal Dosimetry 胸腹部肿瘤 放疗计划验证 Real-time position management respiratory gating Portal Dosimetry Chest and abdominal tumors Radiotherapy plan verification
  • 相关文献

参考文献7

二级参考文献55

  • 1应倩,汪媛.肝癌流行现况和趋势分析[J].中国肿瘤,2020,0(3):185-191. 被引量:103
  • 2张惠玲,李勤,全红,韩军.MatriXX在IMRT剂量验证中的应用[J].中国医学物理学杂志,2011,28(2):2455-2459. 被引量:16
  • 3McDermott LN, Louwe R J, Sonke JJ, et al. Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device. Med Phys,2004 ,31:285-295.
  • 4Louwe RJ, McDermott LN, Sonke JJ, et al. The long-term stability of amorphous silicon fiat panel imaging devices for dosimetry purposes. Med Phys,2004,31:2989-2995.
  • 5Ben'y SL, Polvorosa CS, Wuu CS. A field size specific backscatter correction algorithm for accurate EPID dosimetry. Med Phys, 2010,37:2425-2434.
  • 6Winkler P , Georg D. An intcreomparison of 11 amorphous silicon EPIDs of the same type: implications for portal dosimetry. Phys Med Biol,2006,51:4189-4200.
  • 7McDermott LN, Nijsten SMJJG, Sonke JJ, et al. Comparison of ghosting effects for three commercial a-Si EPIDs. Med Phys,2006, 33:2448-2451.
  • 8Rowshanfarzad P, Sabet M, O'Connor DJ, et al. Reduction of the effect of non-uniform backscatter from an E-type support arm of a Varian a-Si EPID used for dosimetry. Phys Med Biol,2010,55: 6617-6632.
  • 9Siebers JV, Kim JO, Ko L, et al. Monte Carlo computation of dosimetric amorphous silicon electronic portal images. Med Phys, 2004,31:2135-2146.
  • 10Parent L, Scco J, Evans PM, et al. Monte Carlo modelling of a-Si EPID response:the effect of spectral variations with field size and position. Med Phys, 2006, 33:4527-4540.

共引文献42

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部